Live Breaking News & Updates on Boglarka Gyurkocza

Stay updated with breaking news from Boglarka gyurkocza. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Actinium Pharma (ATNM) Announces Positive Pivotal Phase 3 SIERRA Trial Results

Actinium Pharma (ATNM) Announces Positive Pivotal Phase 3 SIERRA Trial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Boglarka Gyurkocza , Sandesh Seth , Actinium Pharmaceuticals Inc , European Hematology Association , Actinium Pharmaceuticals , Chief Executive ,

Actinium Announces Positive Pivotal Phase 3 SIERRA Trial Results in an Oral Presentation at the EHA 2023 Congress

/PRNewswire/ Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies,. ....

Matthew Beck , Sandesh Seth , Boglarka Gyurkocza , Investor Relations Communications , Exchange Commission , European Hematology Association , Prnewswire Actinium Pharmaceuticals Inc , Actinium Pharmaceuticals Inc , Chief Executive , Elderly Relapsed , Refractory Acute Myeloid Leukemia , Complete Remission ,

Actinium Pharmaceuticals, Inc. to Highlight Iomab-B Pivotal Phase 3 SIERRA Trial Data at the Transplantation & Cellular Therapy Tandem Meetings of ASTCT and CIBMTR

- Updated Phase 3 SIERRA data to be presented in an oral presentation by Boglarka Gyurkocza, M.D., SIERRA trial investigator from Memorial Sloan Kettering. ....

United States , Salt Lake City , Salt Palace Convention Center , Hans Vitzthum , Boglarka Gyurkocza , Sandesh Seth , James Foran , Avinash Desai , Lifesci Advisors , University Of Texas Md Anderson Cancer Center , American Society For Transplantation , International Blood Marrow Transplant Research , Exchange Commission , Astellas Pharma Inc , Actinium Pharmaceuticals Inc , European Medicines Agency , Committee For Medicinal Products Human Use , Epicentrx Inc , Fred Hutchinson Cancer Research Center , Mayo Clinical Cancer Center , Memorial Sloan Kettering Cancer Center , Memorial Sloan Kettering Cancer , Patient Journey , Applying Evidence , Novel Therapeutics , Actinium Pharmaceuticals ,